SEC 13F Intelligence

Charles Schwab Investment Management Inc / TMO

Charles Schwab Investment Management Inc’s Thermo Fisher Scientific Inc Position

Does Charles Schwab Investment Management Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 2.93M shares worth $1.4B (+0.22% of its 13F portfolio) as of Q1 2026, up from 2.84M shares the prior filed quarter.

Position Value
$1.4B
Q1 2026
Shares
2.93M
% of Portfolio
+0.22%
Quarters Held
30
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $366MQ4 ’18Q1 ’19: $481MQ2 ’19: $528MQ3 ’19: $537MQ4 ’19: $608MQ4 ’19Q1 ’20: $532MQ2 ’20: $676MQ3 ’20: $846MQ4 ’20: $877MQ4 ’20Q1 ’21: $866MQ2 ’21: $981MQ3 ’21: $1.1BQ4 ’21: $1.3BQ4 ’21Q1 ’22: $1.2BQ2 ’22: $1.1BQ3 ’22: $1.1BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $1.3BQ2 ’23: $1.1BQ3 ’23: $1.1BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.4BQ2 ’24: $1.3BQ3 ’24: $1.5BQ4 ’24: $1.5BQ4 ’24Q1 ’25: $1.5BQ2 ’25: $1.2BQ3 ’25: $1.4BQ4 ’25: $1.6BQ4 ’25Q1 ’26: $1.4Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.93M$1.4B+0.22%
Q4 20252.84M$1.6B+0.26%
Q3 20252.85M$1.4B+0.22%
Q2 20253.00M$1.2B+0.21%
Q1 20252.93M$1.5B+0.27%
Q4 20242.81M$1.5B+0.27%
Q3 20242.44M$1.5B+0.29%
Q2 20242.38M$1.3B+0.25%
Q1 20242.35M$1.4B+0.32%
Q4 20232.28M$1.2B+0.31%
Q3 20232.18M$1.1B+0.32%
Q2 20232.18M$1.1B+0.32%
Q1 20232.19M$1.3B+0.38%
Q4 20222.15M$1.2B+0.38%
Q3 20222.09M$1.1B+0.38%
Q2 20222.06M$1.1B+0.39%
Q1 20222.05M$1.2B+0.36%
Q4 20212.01M$1.3B+0.40%
Q3 20211.97M$1.1B+0.37%
Q2 20211.95M$981M+0.33%
Q1 20211.90M$866M+0.32%
Q4 20201.88M$877M+0.35%
Q3 20201.92M$846M+0.39%
Q2 20201.87M$676M+0.33%
Q1 20201.88M$532M+0.31%
Q4 20191.87M$608M+0.33%
Q3 20191.85M$537M+0.32%
Q2 20191.80M$528M+0.32%
Q1 20191.76M$481M+0.31%
Q4 20181.64M$366M+0.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Charles Schwab Investment Management Inc’s full portfolio or all institutional holders of TMO.